Economics ❯ Healthcare Economics

Cost Reduction

Consumer Impact International Pricing Public Health Healthcare Services Market Comparison Healthcare Affordability Pharmaceutical Industry Patient Access Insurance Costs Consumer Pricing Pharmaceutical Economics Insurance Coverage Insurance Impact Drug Affordability Consumer Access Government Initiatives Tariffs Insurance Programs Negotiated Prices Public Health Spending Government Deals Pharmaceutical Agreements Public Funding Spending Cuts Medicare Savings Prescription Drug Costs

White House Finalizes GLP-1 Price Deal With Lilly and Novo, Setting $50 Medicare Copays

The deal trades steep list-price cuts for expedited FDA reviews and temporary tariff relief.

U.S. Strikes Price-Cut Deals With Novo Nordisk and Eli Lilly for GLP‑1s, With Medicare Pilot in 2026